T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
HEICO Corp
HEI
$52.1B
| $785K | ﹤0.01% |
28,674
-13
| -0% | -$336 |
|
1777
Kaiser Aluminum
KALU
$2.99B
| $782K | ﹤0.01% |
8,650
+2,710
| +46% | +$237K |
|
1778
InterDigital
IDCC
$9.07B
| $777K | ﹤0.01% |
13,950
-2,200
| -14% | -$124K |
|
1779
Otter Tail
OTTR
$3.87B
| $775K | ﹤0.01% |
23,150
+4,300
| +23% | +$129K |
|
1780
Kennametal
KMT
$2.35B
| $770K | ﹤0.01% |
34,846
-4,720
| -12% | -$111K |
|
|
OKSB
1781
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $770K | ﹤0.01% |
45,456
+7,356
| +19% | +$118K |
|
|
CARB
1782
DELISTED
Carbonite Inc
CARB
| $768K | ﹤0.01% |
+78,979
| New | +$693K |
|
|
QLGC
1783
DELISTED
QLOGIC CORP
QLGC
| $768K | ﹤0.01% |
52,122
| – | – |
|
1784
DigitalBridge
DBRG
$2.95B
| $763K | ﹤0.01% |
18,692
+383
| +2% | +$18.2K |
|
|
CPE
1785
DELISTED
Callon Petroleum Company
CPE
| $761K | ﹤0.01% |
6,775
+10
| +0.1% | +$1.07K |
|
1786
Park National Corp
PRK
$3.72B
| $760K | ﹤0.01% |
8,285
+1,590
| +24% | +$145K |
|
1787
Texas Roadhouse
TXRH
$14.1B
| $757K | ﹤0.01% |
16,590
| – | – |
|
1788
New York Times
NYT
$10.3B
| $756K | ﹤0.01% |
62,500
| – | – |
|
1789
Empire State Realty Trust
ESRT
$817M
| $755K | ﹤0.01% |
39,777
-12,500
| -24% | -$235K |
|
|
LGF
1790
DELISTED
Lions Gate Entertainment
LGF
| $754K | ﹤0.01% |
37,295
+6,200
| +20% | +$130K |
|
1791
Westlake Corp
WLK
$10.1B
| $752K | ﹤0.01% |
17,529
+5,549
| +46% | +$253K |
|
|
CSH
1792
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $751K | ﹤0.01% |
17,630
+4,300
| +32% | +$166K |
|
1793
TSMC
TSM
$2.23T
| $747K | ﹤0.01% |
28,467
-130,010
| -82% | -$3.24M |
|
1794
Darling Ingredients
DAR
$10B
| $746K | ﹤0.01% |
50,035
-20,100
| -29% | -$291K |
|
|
ELLI
1795
DELISTED
Ellie Mae Inc
ELLI
| $741K | ﹤0.01% |
8,080
+5,400
| +201% | +$459K |
|
1796
Lumentum
LITE
$78B
| $740K | ﹤0.01% |
30,595
+60
| +0.2% | +$1.49K |
|
|
HA
1797
DELISTED
Hawaiian Holdings, Inc.
HA
| $739K | ﹤0.01% |
+19,465
| New | +$824K |
|
1798
Metallus
MTUS
$900M
| $737K | ﹤0.01% |
76,600
+23,500
| +44% | +$245K |
|
|
GNC
1799
DELISTED
GNC Holdings, Inc.
GNC
| $736K | ﹤0.01% |
30,318
+38
| +0.1% | +$1.05K |
|
1800
Neogen
NEOG
$2.5B
| $734K | ﹤0.01% |
34,800
-7,200
| -17% | -$134K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.